Skip to Content
Merck
All Photos(2)

Key Documents

View All Documentation

473049

Sigma-Aldrich

(1S,4S)-(−)-2-Boc-2,5-diazabicyclo[2.2.1]heptane

95%

Synonym(s):

tert-Butyl (1S,4S)-(−)-2,5-diazabicyclo[2.2.1]heptane-2-carboxylate

Sign Into View Organizational & Contract Pricing
All Photos(2)

About This Item

Empirical Formula (Hill Notation):
C10H18N2O2
CAS Number:
113451-59-5
Molecular Weight:
198.26
MDL number:
MFCD01569250
UNSPSC Code:
12352005
PubChem Substance ID:
24870862
NACRES:
NA.22

Quality Level

100

Assay

95%

optical activity

[α]22/D −44°, c = 1 in chloroform

mp

74-76 °C (lit.)

SMILES string

CC(C)(C)OC(=O)N1C[C@@H]2C[C@H]1CN2

InChI

1S/C10H18N2O2/c1-10(2,3)14-9(13)12-6-7-4-8(12)5-11-7/h7-8,11H,4-6H2,1-3H3/t7-,8-/m0/s1

InChI key

UXAWXZDXVOYLII-YUMQZZPRSA-N

Related Categories

Application

(1S,4S)-(-)-2-Boc-2,5-diazabicyclo[2.2.1]heptane may be used in the preparation of 2-boc-5-(4-nitrophenyl)-2,5-diaza-bicyclo[2.2.1]heptane by reacting with p-nitrobenzene.
It may also be used to develop:
  • indazolylpyrazolo[1,5-a]pyrimidine analogs based B-Raf inhibitors
  • CCR2 antagonists
  • α4β2 nicotinic acetylcholine receptor (nAChR) partial agonists
  • azabicyclic sulfonamide based 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) inhibitors

Storage Class Code

11 - Combustible Solids

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Design and synthesis of novel CCR2 antagonists: Investigation of non-aryl/heteroaryl binding motifs.
Trujillo JI, et al.
Bioorganic & Medicinal Chemistry Letters, 21(6), 1827-1831 (2011)
4-(Phenylaminomethylene) isoquinoline-1, 3 (2H,4H)-diones as potent and selective inhibitors of the cyclin-dependent kinase 4 (CDK4).
Tsou HR, et al.
Journal of Medicinal Chemistry, 51(12), 3507-3525 (2008)
Synthesis and biological evaluation of novel hybrids of highly potent and selective a4?2-Nicotinic acetylcholine receptor (nAChR) partial agonists.
Zhang HK, et al.
European Journal of Medicinal Chemistry, 124, 689-697 (2016)
Indazolylpyrazolopyrimidine as highly potent B-Raf inhibitors with in vivo activity.
Wang Xi, et al.
Journal of Medicinal Chemistry, 53(21), 7874-7878 (2010)
Azabicyclic sulfonamides as potent 11?-HSD1 inhibitors.
Shah U, et al.
Bioorganic & Medicinal Chemistry Letters, 20(5), 1551-1554 (2010)

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service